Lantheus Holdings, Inc.'s stock soars 55%, fueled by Pylarify and strategic acquisitions in Alzheimer's and oncology. Click ...

Charles Schwab Investment Management Inc. cut its stake in Lantheus Holdings, Inc. (NASDAQ:LNTH – Free Report) by 0.5% in the fourth quarter, according to its most recent 13F filing with the ...

PSMA-PET imaging represents a significant advancement in prostate cancer management, providing clinicians with more information than conventional imaging methods (bone scan, CT[4] scan) thereby ...

PSMA-PET imaging represents a significant advancement in prostate cancer management, providing clinicians with more information than conventional imaging methods (bone scan, CT[4] scan) thereby ...

A key advantage of Illuccix is that the radioisotope (gallium-68) can be produced using a generator locally ... imaging agent, technetium-99m (99m Tc) besilesomab, marketed under the brand ...

It provides DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for ... an injectable Tc-99m-labeled imaging agent to assess ...

Telix's osteomyelitis (bone infection) imaging agent, technetium-99m (99m Tc) besilesomab, marketed under the brand name Scintimun®, is approved in 32 European countries and Mexico. Telix's ...

A key advantage of Illuccix is that the radioisotope (gallium-68) can be produced using a generator locally ... Telix’s osteomyelitis (bone infection) imaging agent, technetium-99m (99m Tc) ...